This may be an interesting issue for discussion. To me, a partnership is "only" possible. We are only at the beginning of finding indications for 434; MSA will not be the only indication. Now I am talking about the 434 buy-out and not the company buy-out. The company has many more potential molecules, but the value of them is difficult to estimate since no reports of them have been published.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $119.6M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.4¢ | $10.67K | 762.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 24215222 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 15822627 | 14 |
View Market Depth
| Last trade - 09.59am 21/08/2025 (20 minute delay) ? |
| ATH (ASX) Chart |